In a clinical guideline issued by the American College of Physicians and published online Feb. 4 in the Annals of Internal ...

Company plans to initiate a Phase 1/b trial in relapsed/refractory, locally advanced/metastatic bladder cancer by year-end ...

The European Commission (EC) has already approved Valneva’s chikungunya vaccine Ixchiq for use in individuals aged 18 years ...

Drosera acts as Ethereum’s immune system by arming protocols with the ability to detect and neutralize threats before they ...

Thanks to a social media firestorm and a last-minute court injunction, 400 ostriches that were facing a culling on 1 February ...

We’re kicking off a brand-new monthly tradition! Each month, the editors of LCGC International will select the Top 10 ...

It is unclear why an independent data safety monitoring board recommended the suspension of Pliant’s Phase IIb/III BEACON-IPF ...

Based on continued emergence of bempikibart data from SIGNAL-AA Part A, including strong re-consent rates and patient demand for continued dosing, Company initiating ...

As clinical trial complexity, duration, and cost continue to rise, life sciences companies are turning to data to help them ...

Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/105.OtgQHJex.js ...

New Trump Administration tariffs on Canada, Mexico, and China. On , 2025, President Donald Trump signed three Executive Orders ...